Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:16AM EDT. Market open.
| Previous close | 125.91 |
| Open | 126.52 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 126.08 - 127.94 |
| 52-week range | 119.59 - 148.62 |
| Volume | |
| Avg. volume | 1,034,317 |
| Market cap | 14.183B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 17.05 |
| EPS (TTM) | 7.49 |
| Earnings date | 23 Apr 2024 |
| Forward dividend & yield | 3.00 (2.38%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | 142.29 |
ZacksEarnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksQuest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
ZacksMyriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
© 2024 Yahoo. All rights reserved.